NIH-funded research Fellowship grant

Understanding how nuclear proteins affect immune responses in cancer

Official title: Determining the role of nuclear envelope reformation proteins in regulating the cGAS/STING innate immune response in cancer

Funded at Yale University · NIH-10912518 · Data updated 2026-11-12

This study is looking at how certain proteins that help rebuild the cell's protective layer can affect the immune system's response to cancer, with the goal of finding better ways to improve cancer treatments for patients.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2026
Funding year2024
Award (this year)$48,974
NIH project number5F31CA278423-02
Project IDNIH-10912518 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with cancer who may benefit from enhanced immunotherapy approaches.

Less likely to help

Patients with non-cancerous conditions or those not undergoing immunotherapy may not receive any benefit from this research.

What this research studies

This research investigates how certain proteins involved in the reformation of the nuclear envelope influence the immune response to cancer cells. It focuses on the cGAS/STING pathway, which detects DNA from damaged cancer cells and can either help or hinder cancer treatment. By using specific DNA models, the research aims to uncover the interactions between these nuclear proteins and the immune response, potentially leading to new therapeutic strategies. Patients may benefit from insights that could improve immunotherapy effectiveness.

Why it matters

Potential benefit: If successful, this research could lead to improved cancer treatments by enhancing the effectiveness of immunotherapies.

How similar studies have gone: Other research has shown promising results in understanding immune responses in cancer, but the specific role of nuclear envelope reformation proteins in this context is still being explored.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Isenhour, Anthony Wayne — Yale University
  • Study coordinator: Isenhour, Anthony Wayne

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.